Form 4: Director James Wilson Executes Stock Gift

Corcept Therapeutics Director James N. Wilson reported a gift of 2,000 shares of common stock.

Summary

• Director James N. Wilson transferred 2,000 shares of Corcept Therapeutics (CORT) common stock via a gift transaction.
• The transaction occurred on April 22, 2026, at a price of $0.00 per share.
• Following the transaction, the reporting person maintains indirect beneficial ownership of 1,095,532 shares through the James N. Wilson and Pamela D. Wilson Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a non-market gift that does not signal a change in confidence from the director.

Positives

• The transaction was a charitable or personal gift rather than a market sale, indicating no change in long-term investment thesis.

Negatives

• Minor reduction in total shares held indirectly by the reporting person.

Risks

• None identified in this filing.

Future Outlook

Not applicable for this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider gift filings are routine corporate governance disclosures and generally do not reflect management's view on the company's operational performance or future stock price trajectory.

Comparison to Industry Standards

• The filing follows standard SEC reporting requirements for Section 16 insiders.
• Gift transactions are common among board members of mid-cap biotechnology firms.

Related Party Transactions

• The reporting person maintains voting power over shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a gift and not a divestment.

Key Dates

Keywords

Corcept Therapeutics, CORT, Insider Trading, Form 4, Director, Stock Gift